Skip to main content
Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study.
A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group.
Identifying clinical practice guidelines for the supportive care of children with cancer: A report from the Children's Oncology Group.
Comment on: Olanzapine for chemotherapy-induced nausea: Lessons learned from child and adolescent psychiatry.
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.
Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.
Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma.
Isolated late testicular relapse of B-cell acute lymphoblastic leukemia treated with intensive systemic chemotherapy and response-based testicular radiation: A Children's Oncology Group study.
Nitrous gas analgesia and sedation for lumbar punctures in children: Has the time for practice change come?